- Home
- ARMP vs CODA Comparison
ARMP vs CODA Comparison
Compare ARMP & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- CODA
- Stock Information
- Founded
- ARMP N/A
- CODA 1994
- Country
- ARMP United States
- CODA United States
- Employees
- ARMP N/A
- CODA N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- CODA Industrial Machinery/Components
- Sector
- ARMP Health Care
- CODA Industrials
- Exchange
- ARMP Nasdaq
- CODA Nasdaq
- Market Cap
- ARMP 80.0M
- CODA 92.5M
- IPO Year
- ARMP N/A
- CODA N/A
- Fundamental
- Price
- ARMP $2.11
- CODA $7.77
- Analyst Decision
- ARMP Strong Buy
- CODA Strong Buy
- Analyst Count
- ARMP 1
- CODA 1
- Target Price
- ARMP $7.00
- CODA $11.00
- AVG Volume (30 Days)
- ARMP 8.2K
- CODA 28.3K
- Earning Date
- ARMP 03-20-2025
- CODA 03-17-2025
- Dividend Yield
- ARMP N/A
- CODA N/A
- EPS Growth
- ARMP N/A
- CODA 14.29
- EPS
- ARMP N/A
- CODA 0.32
- Revenue
- ARMP $5,467,000.00
- CODA $20,316,161.00
- Revenue This Year
- ARMP $23.87
- CODA $31.72
- Revenue Next Year
- ARMP N/A
- CODA $12.23
- P/E Ratio
- ARMP N/A
- CODA $24.28
- Revenue Growth
- ARMP 34.92
- CODA 4.98
- 52 Week Low
- ARMP $1.80
- CODA $5.48
- 52 Week High
- ARMP $4.48
- CODA $9.89
- Technical
- Relative Strength Index (RSI)
- ARMP 56.44
- CODA 41.75
- Support Level
- ARMP $1.85
- CODA $7.77
- Resistance Level
- ARMP $2.08
- CODA $8.58
- Average True Range (ATR)
- ARMP 0.12
- CODA 0.23
- MACD
- ARMP 0.00
- CODA 0.00
- Stochastic Oscillator
- ARMP 56.67
- CODA 2.41
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.